combined pd1 and ido1 inhibiton in patients with clear cell carcinoma of the ovary
Published 1 year ago • 676 plays • Length 2:10Download video MP4
Download video MP3
Similar videos
-
3:26
phase ii trial of pembro & epacadostat in patients with recurrent clear cell carcinoma of the ovary
-
1:52
efficacy of targeted therapies after pd-1/pd-l1 blockade in metastatic renal cell carcinoma
-
1:37
dr. hammers discusses combining ido and pd-1 inhibitors in rcc
-
8:00
digital pathology sign out 27 1 clear cell carcinoma of the ovary
-
4:34
pd-1 inhibition in renal cell carcinoma
-
7:06
pd-1 inhibition in metastatic renal cell carcinoma
-
2:19
rini explores pd-1 inhibition in renal cell carcinoma
-
1:21
treating pd-1/pd-l1 refractory mcc
-
4:10
combination of medi0680, an anti-pd-1 antibody, with durvalumab, an anti-pd-l1 antibody
-
7:22
pd-1 inhibition in lung cancer
-
57:55
mixed clear cell and serous carcinoma of the ovary
-
7:09
hobnail cells in clear cell carcinoma- ovary and cytologic samples
-
3:36
medi5752: first-in-human trial of a novel pd-1 and ctla-4 bispecific checkpoint inhibitor
-
2:03
integrated genomic correlates of response to pd-1 inhibitor nivolumab in mrcc
-
3:45
pd-1 combinations explored in rcc
-
3:29
are there clinically significant distinctions between pd-1 and pd-l1?
-
3:48
pd-1 inhibitor use in kidney and bladder cancers
-
1:24
kd033, a pdl1-1l15 bispecific molecule for the treatment of cancer